retatrutide mechanism of action clinical trials What is the of Retatrutide? Retatrutide Before and After: Doctor

The same is true of other GLP-1 medications

Treatment persistence data further underscores this concern

Requires a Mochi Health Membership

Common side effects include nausea, diarrhea, vomiting, constipation, stomach pain, headache, tiredness, upset stomach, dizziness, feeling bloated, belching, gas, stomach flu, heartburn, runny nose and a sore throat

Tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 receptor agonist (GLP-1 RA), has shown superior efficacy in glycemic control, weight loss and cardiometabolic outcomes compared to GLP-1 agonists alone

However, more data from large-scale randomised trials and longer treatment and follow-up periods are needed to establish the long-term efficacy of GLP-1 RAs, as well as future studies exploring whether these medications might be useful for the direct treatment of mental health disorders." Source: Journal reference: Breit, S., & Hubl, D